The literature provides contrasting results on the efficacy of levetiracetam (LEV) in multiple sclerosis (MS) patients with cerebellar signs. It was sought to evaluate the efficacy of LEV on upper limb movement in MS patients.
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study
Patti, F
2020-01-01
Abstract
The literature provides contrasting results on the efficacy of levetiracetam (LEV) in multiple sclerosis (MS) patients with cerebellar signs. It was sought to evaluate the efficacy of LEV on upper limb movement in MS patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
301.36 kB
Formato
Adobe PDF
|
301.36 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
